A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease

NCT02641392 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
310
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated by Sponsor following a recommendation from external DMC based on lack of emerging benefit; there were no new emergent safety findings

Conditions

Interventions

Sponsor

Celgene